NFL BIOSCIENCES Publishes Study on NFL-101 Mechanism of Action

NFL BIOSCIENCES announced the publication of a scientific study on the mechanism of action of its drug candidate, NFL-101. The research was conducted by the Commissariat à l'Énergie Atomique et aux Énergies Alternatives (CEA) and published in ACS Chemical Neuroscience.

NFL-101 is being investigated for its potential to aid in smoking cessation. The study delves into the molecular interactions and pathways involved in its mechanism. Understanding these interactions is crucial for further development. It also highlights the innovative approach NFL BIOSCIENCES is taking in the field of addiction treatment.

The findings are significant for both the scientific community and potential future patients. They offer insights that could lead to more effective treatments for nicotine dependence. This publication marks a notable milestone for NFL BIOSCIENCES in its quest to develop new bio-based therapies.